Article
The R1441C mutation of LRRK2 disrupts GTP hydrolysis.
Biochemical and biophysical research communications - 8 Jun 2007
Lewis Patrick A, Greggio Elisa, Beilina Alexandra, Jain Shushant, Baker Acacia, Cookson Mark R
Abstract excerpt
Mutations in Leucine Rich Repeat Kinase 2 (LRRK2) are the leading genetic cause of Parkinson's disease (PD). LRRK2 is predicted to contain kinase and GTPase enzymatic domains, with recent evidence suggesting that the kinase activity of LRRK2 is central to the pathogenic process associated with this protein. The GTPase domain of LRRK2 plays an important role in the regulation of kinase activity. To investigate how...
Topics
- Amino Acid Substitution
- Animals
- COS Cells
- Chlorocebus aethiops
- GTP Phosphohydrolases
- Guanosine Diphosphate
- Guanosine Triphosphate
- Humans
- Hydrolysis
- Immunoblotting
- Immunoprecipitation
